Unknown

Dataset Information

0

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.


ABSTRACT: The nasal type of extranodal natural killer/T-cell lymphoma is a rare aggressive lymphoma with poor prognosis. To discover a successful treatment, we investigated the efficacy and safety of chemotherapy with methotrexate, etoposide, dexamethasone, and polyethylene glycol-asparaginase (MESA). Three cycles of MESA were administered to 46 patients with new or relapsed/refractory natural killer/T-cell lymphoma. Complete response after 3 treatment cycles was 43.5%, the overall response rate was 87%, and 2-year overall survival was 83.4%. Complete response was significantly better for newly diagnosed patients than for patients with relapsed/refractory disease. Patients with newly diagnosed disease had a significantly better overall response rate after 1, but not after 2 or 3 treatment cycles. Overall survival and progression-free survival did not differ over 2 years. Grade 1/2 toxicities were frequent, but MESA was associated with fewer grade 3/4 events or treatment-related deaths. These results will require confirmation in larger prospective trials.

SUBMITTER: Liang R 

PROVIDER: S-EPMC5763273 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.

Liang Rong R   Gao Guang-Xun GX   Chen Jie-Ping JP   Wang Ji-Shi JS   Wang Xiao-Min XM   Zeng Yun Y   Bai Qing-Xian QX   Zhang Tao T   Yang Lan L   Dong Bao-Xia BX   Gu Hong-Tao HT   Shu Mi-Mi MM   Hao Cai-Xia CX   Wang Jian-Hong JH   Zhang Na N   Chen Xie-Qun XQ  

Hematological oncology 20161010 4


The nasal type of extranodal natural killer/T-cell lymphoma is a rare aggressive lymphoma with poor prognosis. To discover a successful treatment, we investigated the efficacy and safety of chemotherapy with methotrexate, etoposide, dexamethasone, and polyethylene glycol-asparaginase (MESA). Three cycles of MESA were administered to 46 patients with new or relapsed/refractory natural killer/T-cell lymphoma. Complete response after 3 treatment cycles was 43.5%, the overall response rate was 87%,  ...[more]

Similar Datasets

| S-EPMC5704067 | biostudies-literature
| S-EPMC5295438 | biostudies-literature
| S-EPMC10173773 | biostudies-literature
| S-EPMC5342448 | biostudies-literature
| S-EPMC5564839 | biostudies-other
| S-EPMC4221378 | biostudies-literature
| S-EPMC6056977 | biostudies-literature
| S-EPMC6476925 | biostudies-literature
| S-EPMC8350702 | biostudies-literature
| S-EPMC7317673 | biostudies-literature